CEACAM5-eiwit (C-His, mens)

CEACAM5

CD66e, CEA

C-His

≥ 95 % as determined by SDS-PAGE. ≥ 95 % as determined by SEC-HPLC. ≥ 95 % as determined by SEC-MALS (Routinely tested) .

1.Immobilized Anti-CEA Antibody (Research Grade Labetuzumab Biosimilar) at 2 μg/mL (100μL/well) can bind Recombinant Human CEACAM5 / CD66e Protein (His Tag) (Cat: 11077-H08H-UE) . The protein exhibited stable performance after 21 days of storage at 37°C, as measured on Day 0, Day 7, Day 14 and Day 21. 2.Loaded Anti-CEA (Research Grade Labetuzumab Biosimilar) on ProA Biosensor, can bind Recombinant Human CEACAM5 / CD66e Protein (His Tag) (Cat. No. 11077-H08H-UE) with an affinity constant of 6.64 nM as determined in BLI assay (Sartorius Octet RED384) (Routinely tested) .

Met1-Ala685

The secreted recombinant human CEACAM5 consists of 662 amino acids and has a predicted molecular mass of 72.8 kDa. In SDS-PAGE under reducing conditions, the apparent molecular mass of human CEACAM5 is approximately 128 and 154.7 kDa due to different glycosylation. The molecular weight of this protein is around 184.5 kDa verified by SEC-MALS (Routinely tested) .

Human